Fantasma Games (“Fantasma” eller “Bolaget”) publicerade den 11 maj sin första kvartalsrapport för år...
Duearity AB (”Duearity” eller ”Bolaget”) erbjuder unika lösningar för lindring och behandling av tin...
Redeye comments on Sprint’s Q1 2022 report, with the company recently announcing the target and laun...
Hoylu ökade återkommande intäkter med 39 procent för årets första kvartal och genererade hela 14 nya...
Mangold tar upp bevakning av Miris med rekommendation Köp och en riktkurs på 3,00 kronor per aktie p...
Hög aktivitet I takt med att den kliniska aktiviteten har tilltagit, tre kliniska studier som pågår ...
Imponerande Q1'22 ITAB rapporterade en EBIT på 92 mkr (102), 113 mkr (116) exklusive jämförelsestöra...
Rapid growth due to demand for Studio’s services We raise sales estimates by 6.
Redeye comments on Bredband2’s Q1’22, revealed earlier this morning.
Redeye sees a stable Q1 report from Speqta, with the disclosed numbers regarding Bidbrain being the ...
Ascelia can point to considerable professional interest and confirmed scientific support ahead of th...
Strong growth momentum continued into Q2 A transformative year with platform ramp-up from April Shar...
Redeye comments on Adverty’s Q1’22 report. Both sales and profitability came in below our estimates.
Redeye states that the Q1 report from FlexQube was solid with record sales and order intake.
Redeye updates its view on G5 following its Q1-results where the company’s hiked near-term UA invest...
Redeye states that the Q1 report was good, especially within Wireless.
Strong Q1 beat driven by Principal Investments and PIM Underlying EPS estimates raised by 16% for 20...
NoHo Partners' Q1 2022 results came in above Infront consensus expectations and it issued new guidan...
Redeye return with a second comment following BIMobject's Q1-figures which were slightly above estim...
Physitrack stays strong despite external disruptions We add Champion Health to the figures Share tr...
